Standard BioTools Inc. Earnings Per Share (Basic)
Standard BioTools Inc. (LAB) reported Earnings Per Share (Basic) of -$0.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- Standard BioTools Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
- Standard BioTools Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.33.
- Standard BioTools Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.05.
- Standard BioTools Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.09.
- Standard BioTools Inc. earnings per share, basic for fiscal 2025 was -$0.20.
- Standard BioTools Inc. earnings per share, basic for fiscal 2024 was -$0.52.
- Standard BioTools Inc. earnings per share, basic for fiscal 2023 was -$0.94.
- Standard BioTools Inc. earnings per share, basic for fiscal 2022 was -$2.43.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.07 10-Q · filed 2026-08-05 | $0.26 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $0.33 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $0.05 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.20 10-K · filed 2026-03-16 |
| 2025-09-30 | -$0.09 10-Q · filed 2025-11-04 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.25 10-Q · filed 2025-11-04 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$0.09 10-Q · filed 2026-08-05 | -$0.16 10-Q · filed 2026-08-05 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$0.07 10-Q · filed 2026-05-06 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-05-06 |
| 2024-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.52 10-K · filed 2026-03-16 |
| 2024-09-30 | -$0.07 10-Q · filed 2025-11-04 | -$0.20 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.44 10-Q · filed 2025-11-04 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-03-16 |
| 2024-06-30 | -$0.12 10-Q · filed 2025-08-15 | -$0.37 10-Q · filed 2025-08-15 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-03-16 |
| 2024-03-31 | -$0.27 10-Q · filed 2025-05-06 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-03-16 |
| 2023-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$0.94 10-K · filed 2026-03-16 |
| 2023-09-30 | -$0.27 10-Q · filed 2024-11-06 | -$0.48 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$0.69 10-Q · filed 2024-11-06 | |
| 2023-06-30 | -$0.22 10-Q · filed 2024-08-06 | -$0.43 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$0.21 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$2.43 10-K · filed 2025-03-11 | |||
| 2022-09-30 | -$0.37 10-Q · filed 2023-11-07 | -$2.17 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | -$0.82 10-Q · filed 2023-08-08 | -$1.81 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.99 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$0.78 10-K · filed 2023-03-14 | |||
| 2021-09-30 | -$0.18 10-Q · filed 2022-11-09 | -$0.66 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$0.23 10-Q · filed 2022-08-09 | -$0.48 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.25 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | -$0.74 10-K · filed 2022-03-08 | |||
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-09 | -$0.49 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$0.18 10-Q · filed 2021-08-06 | -$0.41 10-Q · filed 2021-08-06 | ||
| 2019-12-31 | -$0.97 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |